Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with philadelphia chromosome-positive or BCR-ABL-positive acute lymphoblastic leukemia: A Canadian consensus

Stephen Couban; L. Savoie; Y. A. Abou Mourad; B. Leber; M. Minden; R. Turner; V. Palada; N. Shehata; A. Christofides; S. Lachance

doi:10.3747/co.21.1834

Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with philadelphia chromosome-positive or BCR-ABL-positive acute lymphoblastic leukemia: A Canadian consensus

Stephen Couban, L. Savoie, Y. A. Abou Mourad, B. Leber, M. Minden, R. Turner, V. Palada, N. Shehata, A. Christofides, S. Lachance

Research output: Contribution to journal › Article › peer-review

14 Citations (Scopus)

Original language	English
Pages (from-to)	e265-e309
Journal	Current Oncology
Volume	21
Issue number	2
DOIs	https://doi.org/10.3747/co.21.1834
Publication status	Published - 2014
Externally published	Yes

ASJC Scopus Subject Areas

Oncology

Keywords

ALL
Acute lymphoblastic leukemia
Hematology
Philadelphia chromosome-positive
Tyrosine kinase inhibitors

Access to Document

10.3747/co.21.1834

Cite this

Couban, S., Savoie, L., Abou Mourad, Y. A., Leber, B., Minden, M., Turner, R., Palada, V., Shehata, N., Christofides, A., & Lachance, S. (2014). Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with philadelphia chromosome-positive or BCR-ABL-positive acute lymphoblastic leukemia: A Canadian consensus. Current Oncology, 21(2), e265-e309. https://doi.org/10.3747/co.21.1834

Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with philadelphia chromosome-positive or BCR-ABL-positive acute lymphoblastic leukemia: A Canadian consensus. / Couban, Stephen; Savoie, L.; Abou Mourad, Y. A. et al.
In: Current Oncology, Vol. 21, No. 2, 2014, p. e265-e309.

Research output: Contribution to journal › Article › peer-review

Couban, S, Savoie, L, Abou Mourad, YA, Leber, B, Minden, M, Turner, R, Palada, V, Shehata, N, Christofides, A & Lachance, S 2014, 'Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with philadelphia chromosome-positive or BCR-ABL-positive acute lymphoblastic leukemia: A Canadian consensus', Current Oncology, vol. 21, no. 2, pp. e265-e309. https://doi.org/10.3747/co.21.1834

@article{ba95eb39cb6e44089f3682ea8b40a892,

title = "Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with philadelphia chromosome-positive or BCR-ABL-positive acute lymphoblastic leukemia: A Canadian consensus",

keywords = "ALL, Acute lymphoblastic leukemia, Hematology, Philadelphia chromosome-positive, Tyrosine kinase inhibitors",

author = "Stephen Couban and L. Savoie and {Abou Mourad}, {Y. A.} and B. Leber and M. Minden and R. Turner and V. Palada and N. Shehata and A. Christofides and S. Lachance",

year = "2014",

doi = "10.3747/co.21.1834",

language = "English",

volume = "21",

pages = "e265--e309",

journal = "Current Oncology",

issn = "1198-0052",

publisher = "Multimed Inc.",

number = "2",

}

TY - JOUR

T1 - Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with philadelphia chromosome-positive or BCR-ABL-positive acute lymphoblastic leukemia

T2 - A Canadian consensus

AU - Couban, Stephen

AU - Savoie, L.

AU - Abou Mourad, Y. A.

AU - Leber, B.

AU - Minden, M.

AU - Turner, R.

AU - Palada, V.

AU - Shehata, N.

AU - Christofides, A.

AU - Lachance, S.

PY - 2014

Y1 - 2014

KW - ALL

KW - Acute lymphoblastic leukemia

KW - Hematology

KW - Philadelphia chromosome-positive

KW - Tyrosine kinase inhibitors

UR - http://www.scopus.com/inward/record.url?scp=84898787747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898787747&partnerID=8YFLogxK

U2 - 10.3747/co.21.1834

DO - 10.3747/co.21.1834

M3 - Article

AN - SCOPUS:84898787747

SN - 1198-0052

VL - 21

SP - e265-e309

JO - Current Oncology

JF - Current Oncology

IS - 2

ER -

Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with philadelphia chromosome-positive or BCR-ABL-positive acute lymphoblastic leukemia: A Canadian consensus

ASJC Scopus Subject Areas

Keywords

Access to Document

Other files and links

Fingerprint

Cite this